1.
Cardiac toxicity associated with HCV direct antiviral agents: Heart in HCV DAAs therapy. Mediterr J Hematol Infect Dis [Internet]. 2018 Oct. 29 [cited 2026 May 14];10(1):e2018069. Available from: https://www.mjhid.org/mjhid/article/view/2018.069